 CAMBRIDGE, Mass.--BUSINESS WIRE--Syros Pharmaceuticals Nasdaq: SYRS Syros or the Company, a leader in the development of medicines that control the expression of genes, today announced the grant of an inducement stock option award to Conley Chee, the Companys recently hired Chief Commercial Officer, in accordance with Mr. Chees employment offer letter. The grant was approved by the Companys Board of Directors and was made as a material inducement to Mr. Chees acceptance of employm 